PMID- 30298565 OWN - NLM STAT- MEDLINE DCOM- 20190404 LR - 20220720 IS - 1528-1167 (Electronic) IS - 0013-9580 (Print) IS - 0013-9580 (Linking) VI - 59 IP - 11 DP - 2018 Nov TI - Effects of galanin receptor 2 and receptor 3 knockout in mouse models of acute seizures. PG - e166-e171 LID - 10.1111/epi.14573 [doi] AB - There exists solid evidence that endogenous galanin and galanin agonists exert anticonvulsive actions mediated both by galanin 1 receptor (GAL1-R) and galanin 2 receptor (GAL2-R). We have now investigated whether depletion of the recently identified third galanin receptor, GAL3-R, and that of GAL2-R, alters the threshold to the systemically applied gamma-aminobutyric acid (GABA) antagonist pentylenetetrazole (PTZ) or to intrahippocampally administered kainic acid (KA). In neither model, GAL3-KO mice differed in their latency to the first seizure, mean seizure duration, total number of seizures, or time spent in seizures compared to wild-type controls. In addition, consistent with previous data, the response to PTZ was not altered in GAL2-KO mice. In contrast, intrahippocampal KA resulted in a significantly increased number of seizures and time spent in seizures in GAL2-KO mice, although the latency to the first seizure and the duration of individual seizures was not altered. These results are consistent with the previous data showing that GAL2-R knockdown does not affect the number of perforant path stimulations required for initiating status epilepticus but significantly increases the seizure severity during the ongoing status. In conclusion, our data support a specific role of GAL2-R but not of GAL3-R in mediating the anticonvulsive actions of endogenous galanin. CI - (c) The Authors. Epilepsia published by Wiley Periodicals, Inc. on behalf of International League Against Epilepsy. FAU - Drexel, Meinrad AU - Drexel M AUID- ORCID: 0000-0002-2705-9673 AD - Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria. FAU - Sternberg', Felix AU - Sternberg' F AD - Laura Bassi Centre of Expertise-THERAPEP, Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria. FAU - Kofler, Barbara AU - Kofler B AD - Laura Bassi Centre of Expertise-THERAPEP, Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria. FAU - Sperk, Gunther AU - Sperk G AD - Department of Pharmacology, Medical University of Innsbruck, Innsbruck, Austria. LA - eng SI - GENBANK/TSP075150 GR - P 26680/Austrian Science Fund FWF/Austria PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20181008 PL - United States TA - Epilepsia JT - Epilepsia JID - 2983306R RN - 0 (Receptor, Galanin, Type 2) RN - 0 (Receptor, Galanin, Type 3) RN - SIV03811UC (Kainic Acid) RN - WM5Z385K7T (Pentylenetetrazole) SB - IM MH - Animals MH - Disease Models, Animal MH - Electroencephalography MH - Hippocampus/drug effects MH - Kainic Acid/toxicity MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Knockout MH - Pentylenetetrazole/toxicity MH - Reaction Time/drug effects/genetics MH - Receptor, Galanin, Type 2/*deficiency/genetics MH - Receptor, Galanin, Type 3/*deficiency/genetics MH - Seizures/chemically induced/*genetics PMC - PMC6282553 OTO - NOTNLM OT - GAL2-R OT - GAL3-R OT - hippocampus OT - kainic acid OT - pentylenetetrazole OT - seizure protection EDAT- 2018/10/10 06:00 MHDA- 2019/04/05 06:00 PMCR- 2018/12/06 CRDT- 2018/10/10 06:00 PHST- 2018/08/20 00:00 [received] PHST- 2018/09/07 00:00 [revised] PHST- 2018/09/10 00:00 [accepted] PHST- 2018/10/10 06:00 [pubmed] PHST- 2019/04/05 06:00 [medline] PHST- 2018/10/10 06:00 [entrez] PHST- 2018/12/06 00:00 [pmc-release] AID - EPI14573 [pii] AID - 10.1111/epi.14573 [doi] PST - ppublish SO - Epilepsia. 2018 Nov;59(11):e166-e171. doi: 10.1111/epi.14573. Epub 2018 Oct 8.